Newsroom

DENVER--(BUSINESS WIRE)--MediaKind, a global leader in cloud-based video streaming technology, today announced it has entered into an agreement to acquire the Video Business of Harmonic Inc. (NASDAQ: HLIT) for approximately $145 million. Following a French employee works council consultation process, the parties would immediately execute a purchase agreement, and the transaction would be expected to close in the first half of 2026, subject to customary regulatory approvals and closing condition...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones Internet UCITS ETF 05.12.2025 FDNU IE00BG0SSC32 2,425,002.00 USD 91,445,349.21 37.709  ...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: First Trust Advisors L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be name...

SAN FRANCISCO--(BUSINESS WIRE)--Andersen Consulting enters into a Collaboration Agreement with S-RM, a global intelligence and cybersecurity consultancy....

LEXINGTON, Mass.--(BUSINESS WIRE)--VulnCheck, the exploit intelligence company, today announced two key executive hires as the company continues to scale to meet increasing global demand for its exploit intelligence solutions. Mike Price joins VulnCheck as Vice President of Product & Engineering, and Jon Loehr joins as Vice President of Finance. Price brings decades of experience in cybersecurity and technology leadership to VulnCheck. Most recently, serving as Chief Technology Officer at Z...

CHICAGO--(BUSINESS WIRE)--Adams Street Partners, LLC, a private markets investment management firm with more than $65 billion in assets under management (“Adams Street”), has been named one of the “Best Places to Work in Money Management” for 2025 by Pensions & Investments. The firm’s inclusion on the annual list, which follows a comprehensive application and evaluation process conducted by the publication’s editorial team, marks the eighth consecutive year that Adams Street has received th...

DALLAS--(BUSINESS WIRE)--DLA, LLC is pleased to announce that James McGurn, CFA, has joined the firm as a Managing Director within the Accounting Advisory group. In this leadership role, James will support the continued growth of DLA’s national valuation practice, delivering high-quality financial reporting valuation services to both private and public company clients. James brings 15 years of valuation, financial reporting, and transaction advisory experience, spanning Big Four–adjacent public...

NEW YORK--(BUSINESS WIRE)--Working pet parents take an average of 7.3 days off work annually for pet health issues, according to new findings from Wagmo, the pet healthcare benefit trusted by leading employers. The second annual Working Pet Parent Survey, which polled 1,017 full-time U.S. employees with cats or dogs, reveals that pet health has become a significant workplace productivity issue, with three-quarters of respondents reporting effects on job performance. Seventy-five percent of work...

SOMERVILLE, Mass.--(BUSINESS WIRE)--Genetix Biotherapeutics Inc. today announced real-world data from the commercial implementation of ZYNTEGLO™ and LYFGENIA™, first-in-class ex vivo gene addition therapies for the treatment of beta-thalassemia and sickle cell disease. With over 250 patients treated with these therapies, inclusive of clinical trials and commercial treatments, and long-term follow-up data beyond 10 years, Genetix has the most robust long-term dataset in ex vivo gene therapy for...